 vivo interferon-gamma therapy vitro ability chronic granulomatous disease neutrophils Aspergillus hyphae double-blind placebo-controlled randomized trial recombinant interferon-gamma rIFN-gamma therapy chronic granulomatous disease CGD metabolic assay neutrophil damage Aspergillus fumigatus hyphae neutrophil function therapy assay conidia hyphae CGD neutrophils analysis variance neutrophils patients rIFN-gamma damage placebo group subgroup analysis effect hyphae CGD neutrophils neutrophils patients rIFN-gamma damage hyphae placebo group vivo rIFN-gamma therapy ability CGD neutrophils Aspergillus fumigatus hyphae vitro assay